6 completed, 2 terminated, 1 recruiting. 9 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Terminated 2, Recruiting 1 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow Podophyllotoxin: new trials by email Literature Review of Podophyllotoxin trials Research Report on Podophyllotoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer Atezolizumab, Carboplatin, Cisplatin - Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer | Phase 2 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 63 | 2022-06-27 | 2026-06-25 |
| Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Doxorubicin, Bleomycin, Vinblastine - Lymphoma | Phase 2 | Terminated | ECOG-ACRIN Cancer Research Group | 6 | 2013-05-24 | 2023-06-29 |
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Cisplatin, Etoposide, Veliparib - Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 156 | 2012-09-28 | 2026-06-24 |
| Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery proton beam radiation therapy, cisplatin, etoposide - Stage IIIA Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 34 | 2010-01-01 | 2021-05-17 |
| Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer busulfan, etoposide, intensity-modulated radiation therapy - Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 25 | 2007-06-11 | 2023-11-30 |
| Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma Regimen A, Regimen B - Lymphoma | Phase 2 | Completed | Northwestern University | 25 | 2007-02-06 | 2019-10-15 |
| Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma filgrastim, rituximab, carboplatin - Lymphoma | Phase 2 | Completed | Eastern Cooperative Oncology Group | 100 | 2006-09-26 | 2023-06-29 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer G-CSF, Cisplatin, Etoposide - Extensive Stage Small Cell Lung Cancer | Phase 2 | Completed | Eastern Cooperative Oncology Group | 140 | 2004-07-14 | 2023-07-05 |
| Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma filgrastim, carboplatin, cyclophosphamide - Brain Tumor, Central Nervous System Tumor | Phase 2 | Completed | Children's Oncology Group | 378 | 2003-08-01 | 2019-08-07 |
Lymphoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Anemia, Refractory, with Excess of Blasts (1) · Blast Crisis (1) · Brain Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Small Cell (1) · Central Nervous System Neoplasms (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Large B-Cell, Diffuse (1) · Small Cell Lung Carcinoma (1) · Urinary Bladder Neoplasms (1)
Eastern Cooperative Oncology Group (2) · Abramson Cancer Center at Penn Medicine (1) · Children's Oncology Group (1) · City of Hope Medical Center (1) · ECOG-ACRIN Cancer Research Group (1) · National Cancer Institute (NCI) (1) · Northwestern University (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (9) · Australia (1) · Canada (1) · Netherlands (1) · New Zealand (1) · Switzerland (1)
Anthony Stein (1) · Jacob Shabason, MD (1) · Jean Hoffman-Censits, MD (1) · Joseph Aisner, MD (1) · Leo Gordon, MD (1) · Lode J. Swinnen, MD (1) · Ranjana Advani, MD (1) · Taofeek Owonikoko (1) · Thomas E. Merchant, DO, PhD (1)
PMID 19767508, PMID 24146219, PMID 30523756, PMID 32860331, PMID 37201756
U10CA021115 (3), P30CA060553 (1), U01CA079778 (1), U01CA080098 (1), U10CA180820 (1), U24CA196172 (1)